福安药业(300194.SZ)：子公司参与国家组织集采药品协议期满品种接续采购拟中选

Core Viewpoint - Fuan Pharmaceutical (300194.SZ) announced that its wholly-owned subsidiaries participated in the national organized procurement for the continuation of drug agreements, with 28 drug varieties expected to be selected for procurement [1] Group 1: Company Participation - Fuan Pharmaceutical's subsidiaries, including Qingyutang Pharmaceutical, Ningbo Tianheng Pharmaceutical, Yantai Zhichu Pharmaceutical, and Hubei Renmin Pharmaceutical, engaged in the bidding for the national organized procurement [1] - The procurement is related to the continuation of drug agreements that are set to expire [1] Group 2: Procurement Results - The results of the procurement were published by the Continuation Procurement Office on February 10, 2026, indicating that 28 drug varieties from the company’s subsidiaries are expected to be selected [1]